AI-based health care professional (HCP) targeting in the US enables individualized segmentation, Next-Best-Action orchestration, and closed-loop measurement by integrating three individual-physician-level data layers: prescriber inputs, engagement responses, and outcome feedback. This study asks why these capabilities have not emerged in Korea, using a comparative qualitative analysis grounded in the Technology–Organization–Environment (TOE) framework. The US permits commercial aggregation of individual-level HCP data; Korea's Personal Information Protection Act (PIPA) classifies physician identifiers as personal information and forecloses this pathway at every layer. The three data layers therefore cannot form: rules-based targeting remains viable, but self-improving AI-based targeting is structurally precluded. The paper shows that when AI depends on regulated personal data, regulation determines which class of AI capability emerges, with the binding constraint at the data layer rather than at organizational or algorithmic capacity. For Korea, the path runs through reclassifying prescriber identity and behavioral data as professional rather than personal
목차
Abstract 1. Introduction 2. Literature Review 2.1 HCP Targeting and NBA 2.2 Data Infrastructure 2.3 Privacy Regulation 3. Research Method 3.1 Research Design 3.2 TOE Framework 3.3 Case Selection 3.4 Data Sources and Analytical Procedure 4. The U.S. Case 4.1 Prescriber Data 4.2 Engagement Data 4.3 Outcome Data 5. The Korean Case 5.1 Prescriber Data 5.2 Engagement Data 5.3 Outcome Data 6. Comparative Analysis 6.1 TOE Mapping 7. Discussion 8. Conclusion References